Maryland pharmaceutical company buys maker of overdose reversal drug Narcan for $735 million
The Gaithersburg pharmaceutical company Emergent Biosolutions has bought the maker of Narcan, a widely used opioid overdose reversal drug, and said it plans to develop more products to combat the nationwide opioid addiction and overdose epidemic